Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial-Reference-Cited by-同舟云学术

Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial

Published:2012-02 Issue:2 Volume:39 Page:130-134
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Vehreschild J. Janne,Moritz Gregor,Vehreschild Maria J.G.T.,Arenz Dorothee,Mahne Martina,Bredenfeld Henning,Chemnitz Jens,Klein Florian,Cremer Birgit,Böll Boris,Kaul Ingrid,Wassmer Gernot,Hallek Michael,Scheid Christof,Cornely Oliver A.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference26 articles.

1. Antimicrobial therapy for fever of unknown origin in neutropenia. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology;Link;Dtsch Med Wochenschr,1999

2. Autologous hematopoietic stem-cell transplantation for multiple myeloma;Harousseau;N Engl J Med,2009

3. Managing relapsed and refractory Hodgkin lymphoma;Brice;Br J Haematol,2008

4. Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma;Rifkin;Clin Lymphoma Myeloma Leuk,2010

5. Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration;Hughes;Clin Infect Dis,1992

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibacterial prophylaxis for neutropenic and high‐risk hematology patients—Do the benefits outweigh the risk?;Transplant Infectious Disease;2024-03-08

2. The tale of antibiotics beyond antimicrobials: Expanding horizons;Cytokine;2023-09

3. Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB;Blood Advances;2023-04-26

4. The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer;Infectious Diseases and Therapy;2022-10-14

5. Antimicrobial prophylaxis and the rate of blood stream infections and Clostridioides difficile in pediatric stem cell transplantation: A single‐center retrospective study;Pediatric Transplantation;2022-08-10